Avalon GloboCare Corp. Logo

Avalon GloboCare Corp.

Develops cell-based immunotherapies and provides precision diagnostics and lab services.

ALBT | US

Overview

Corporate Details

ISIN(s):
US05344R3021 (+1 more)
LEI:
Country:
United States of America
Address:
4400 ROUTE 9, 7728 FREEHOLD

Description

Avalon GloboCare Corp. is a commercial-stage company dedicated to developing and delivering transformative healthcare solutions. The company's activities are centered on two main areas: advancing cell-based immunotherapies and providing precision diagnostics with clinical laboratory services. Its therapeutic development focuses on immune effector cell therapies, including Chimeric Antigen Receptor T-cell (CAR-T) technology. In diagnostics, its core technology platforms include the KetoAir™ breathalyzer, which utilizes nanosensor technology, and the QTY protein design platform, a joint intellectual property with the Massachusetts Institute of Technology (MIT). The company also operates clinical laboratories offering an extensive menu of services, such as general bloodwork, anatomic pathology, urine toxicology, and pharmacogenomics (PGx) testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Avalon GloboCare Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Avalon GloboCare Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Avalon GloboCare Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.